Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: Product/Service

Florence Expands Digital Clinical Research Platform to 44 Countries


Today, Florence announced that over 10,000 clinical research sites in 44 countries across six continents now use its digital research platform. These sites manage their internal clinical operations and remotely connect with study sponsors for virtual start-up, monitoring, and source data review. The rapid transition to digital operations in research has resulted in this 30% increase since January.

Florence's software allows research sites to manage patient and regulatory research documents in an intuitive online environment, which helps clinical trials run more efficiently. Clinical trial sponsors?medical device companies, pharma companies?and contract research organizations can use the same software to access sites and manage clinical trials remotely.

"We build software with the goal of making research teams' jobs 10 times easier, so they can spend more time with patients," says Blake Adams, VP of Marketing for Florence. "What's become apparent over the past two years is that by solving these site workflow challenges, we're also opening up digital access to sites for pharma sponsors, an issue which became critical over the past year."

Study sites' ability to manage and share documents came to the forefront during the COVID-19 pandemic, when 76% of monitoring visits were remote. In addition to powering the Pfizer COVID vaccine, Florence's platform hosted 3 of the 5 vaccine studies and helped more than 10,000 study sites keep clinical trials running so medical advancements did not stop.

"When the pandemic hit, we knew our software could help clinical research teams maintain current studies and launch global vaccine studies," said Florence CEO Ryan Jones. "But what's clear from our continued expansion is that clinical research is not going back to paper and manual processes. The impact on medical development timelines, compliance, and patient satisfaction is clear, and no one wants to give that up."

Florence plans to continue its global expansion by working with its network of study sites, sponsors, and patients to build an integrated workflow ecosystem that can make clinical research operations easier.

POWERED BY FLORENCE

Florence's clinical trial software helps more than 10,000 research sites in 44 countries manage their documents, data, and workflows. The Florence platform also provides remote access so sponsors and CROs can collaborate with their sites around the world. Florence users now perform 3 million remote monitoring activities each month. To learn more, visit florencehc.com.


These press releases may also interest you

at 18:00
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

at 18:00
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

at 17:52
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

at 16:30
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: